Net Sales are expected to decrease by 6.7 percent Y-o-Y (up 2.8 percent Q-o-Q) to Rs. 3,043 crore, according to Sharekhan.
Moneycontrol News
@moneycontrolcom
Sharekhan has come out with its third quarter (October-December’ 18) earnings estimates for the Pharma sector. The brokerage house expects Cadila to report net profit at Rs. 382 crore down 29.7% year-on-year (down 8.6% quarter-on-quarter).
Net Sales are expected to decrease by 6.7 percent Y-o-Y (up 2.8 percent Q-o-Q) to Rs. 3,043 crore, according to Sharekhan.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Read MoreFirst Published on Jan 18, 2019 01:53 pm
